Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
July 31, 2026 -69.80M
April 30, 2026 -90.00M
January 31, 2026 -102.90M
October 31, 2025 -98.80M
July 31, 2025 -98.10M
April 30, 2025 -79.20M
January 31, 2025 -96.80M
October 31, 2024 -241.60M
July 31, 2024 -124.10M
April 30, 2024 -74.80M
January 31, 2024 -324.10M
October 31, 2023 -160.80M
July 31, 2023 -92.90M
April 30, 2023 -82.00M
January 31, 2023 -113.30M
October 31, 2022 -99.70M
July 31, 2022 -46.50M
April 30, 2022 -15.70M
January 31, 2022 -1.669B
October 31, 2021 -66.00M
July 31, 2021 -107.60M
April 30, 2021 -141.00M
January 31, 2021 -135.70M
October 31, 2020 -143.20M
July 31, 2020 -51.80M
Date Value
April 30, 2020 -91.10M
January 31, 2020 -78.40M
October 31, 2019 -84.90M
July 31, 2019 -83.70M
April 30, 2019 -53.50M
January 31, 2019 -129.20M
October 31, 2018 -46.50M
July 31, 2018 -52.40M
April 30, 2018 -174.00M
January 31, 2018 -1.245B
October 31, 2017 -88.90M
July 31, 2017 -61.30M
April 30, 2017 -29.00M
January 31, 2017 -202.10M
October 31, 2016 -50.08M
July 31, 2016 -136.95M
April 30, 2016 -125.73M
January 31, 2016 -106.03M
October 31, 2015 -102.06M
July 31, 2015 -66.77M
April 30, 2015 -53.92M
January 31, 2015 -65.20M
October 31, 2014 -1.171B
July 31, 2014 -56.07M
April 30, 2014 -61.63M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. -129.05M
Stryker Corp. -639.00M
Boston Scientific Corp. -1.956B
Intuitive Surgical, Inc. -26.60M
West Pharmaceutical Services, Inc. -43.20M